Related Articles
Clinical significance of blood‑based miRNAs as biomarkers of non‑small cell lung cancer (Review)
Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non‑small cell lung cancer
Serum levels of candidate microRNA diagnostic markers differ among the stages of non‑small‑cell lung cancer
Plasma miR‑145, miR‑20a, miR‑21 and miR‑223 as novel biomarkers for screening early‑stage non‑small cell lung cancer
Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma